MeSH Browser

MeSH Supplementary: golimumab
Unique ID: C529000
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C529000
Entry Term(s): CNTO 148; CNTO-148; Simponi
Pharm Action: Anti-Inflammatory Agents
Immunosuppressive Agents
Tumor Necrosis Factor Inhibitors
Registry Numbers: 91X1KLU43E; 0
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 779
Note: Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX.
Source: Arthritis Rheum. 2008 Apr;58(4):964-75
Date of Entry: 2008/05/20
Revision Date: 2020/12/21

golimumab MeSH Supplementary Concept Data 2025